Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Taxes on Income

v3.26.1
Taxes on Income
 12 Months Ended
Dec. 31, 2025
Taxes on Income [Abstract]  
TAXES ON INCOME

NOTE 13:- TAXES ON INCOME

 

a. General:

 

Israeli tax rate:

 

The Corporate tax rate in Israel relevant to the Company is 23% in 2025, 2024 and 2023.

 

United States:

 

The Company’s United States subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of 21%.

b. Loss before income taxes:

 

The following are the domestic (i.e. Israeli) and foreign components of the Company’s loss before income taxes:

 

    Year ended December 31,  
    2025     2024     2023  
                   
Domestic   $ (46,421 )   $ (49,317 )   $ (43,500 )
Foreign    
-
      
-
      
-
  
                         
Total   $ (46,421 )   $ (49,317 )   $ (43,500 )

 

c. Taxes on income:

 

The reconciliation of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company’s reported income tax (benefit) is as follows:

 

    Year ended December 31,  
    2025     2024     2023  
Loss before income taxes, as reported in the consolidated statements of operations   $ 46,421     $ 49,317     $ 43,500  
Statutory tax rate     23 %     23 %     23 %
                         
Income tax benefit at statutory tax rate   $ (10,677 )   $ (11,343 )   $ (10,005 )
Effect of Non-deductible expenses     2,241       3,573       3,063  
Change in valuation allowance     9,123       7,770       7,508  
Other     (688 )    
-
       (566 )
                         
Reported income taxes benefit   $
-
     $
-
     $
-
  
d. Net operating loss carryforward:

 

As of December 31, 2025, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $195,687 These net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.

 

e. Deferred tax assets and liabilities:

 

Deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.

 

The principal components of the Company’s deferred tax assets are as follows:

  

    December 31  
    2025     2024  
Deferred tax assets:            
    Net operating loss carry forwards   $ 45,008     $ 36,254  
    Research and development     6,156       5,726  
    Employees and payroll accrual     400       352  
    Property and equipment     (9 )     100  
                 
Total deferred tax assets     51,555       42,432  
                 
Valuation allowance     (51,555 )     (42,432 )
                 
Deferred tax assets, net of valuation allowance   $
-
     $
-
  

 

Based on the available evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has been provided.

 

f. Tax assessments:

 

The Israeli entity’s’ income tax assessments are considered final through 2019.

 

g. Unrecognized Tax Benefits:

 

As of December 31, 2025, 2024 and 2023, the Company did not have any unrecognized tax benefits and does not expect that the amount of unrecognized tax benefits will change significantly within the next 12 months. The Company’s accounting policy is to accrue interest and penalties related to an underpayment of income taxes as a component of income tax expense.